Trial NCT05807126

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2023-02710
Secondary IDs: 10551 NCI-2023-02710 UM1CA186690

Last trial update was posted on 2024-03-06

MeSH Interventions

Magrolimab Olaparib Poly(ADP-ribose) Polymerase Inhibitors

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Anatomic Stage IV Breast Cancer AJCC v8 Castration-Resistant Prostate Carcinoma Stage IVB Prostate Cancer AJCC v8

Stopping Reasons

Added per CS0161016, see memo uploaded to trial related documents.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID